TORONTO, ON / ACCESSWIRE / May 3, 2022 / GHP Noetic SciencePsychedelic Pharma Inc. TSXV:PSYF.P "GHP", a capital pool company, and Diamond Therapeutics Inc. "Diamond", a psychedelic drug development company focused on lowdose therapies for mental health, agreed to terminate a previously announced letter of intent the "LOI" between the parties. For more information on... Lire le communiqué |